Aim: To increase the effectiveness of treatment of colorectal cancer followed by metastatic liver lesion.
Material And Methods: This study included 319 patients with colorectal cancer and metastatic liver lesion Gennari grade I, II, and III for the period from 2002 to 2017. All patients received combined treatment.